| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032618 |
| Receipt No. | R000037195 |
| Official scientific title of the study | Treatment of chronic wounds using FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting: A randomized controlled trial |
| Date of disclosure of the study information | 2018/05/17 |
| Last modified on | 2018/05/17 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Treatment of chronic wounds using FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting: A randomized controlled trial | |
| Title of the study (Brief title) | FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting for chronic wounds | |
| Region |
|
|
| Condition | ||
| Condition | Treatment of chronic wounds is a big clinically challenging based on low graft take rates associated with current surgery, and the cell utilization and therapeutic effects for chronic wounds need to be improved. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Treatment of chronic wounds is a big challenging based on low graft take rates. Our previous study had verified the combined approach of surgical split-thickness skin autograft with ReCell® can improve the treatment effects. However, our recent study has found the cell utilization can be further improved.Here, we investigated whether FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting can improve the cell utilization and therapeutic effects for the chronic wounds. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The rate of complete wound healing at 28 days (full re-epithelialization, without any requirement for dressing) |
| Key secondary outcomes | The time to achieve complete wound closure and treatment-related complications, included pain and itching |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | patients received FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting (experimental group) | |
| Interventions/Control_2 | patients received autologous skin cell suspension and Split-thickness skin grafting(control group) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with a chronic wound (defined as a wound that remained unhealed for more than 4 weeks) which required surgical debridement and skin grafting were eligible. | |||
| Key exclusion criteria | 1.Pregnant women and people aged less than 18 years old;
2.Pre-existing medical conditions that could potentially interfere with wound healing; 3.Patients diagnosed with other medical conditions that could hinder wound healing. 4.Patients considered to be at an aesthetic risk and refusal to give consent. |
|||
| Target sample size | 102 | |||
| Research contact person | |
| Name of lead principal investigator | Jiayuan Zhu |
| Organization | The First Affiliated Hospital of Sun Yat-sen University |
| Division name | Department of Burn Surgery |
| Address | 58 Zhongshan Road II, Guangzhou 510080, China |
| TEL | 86-20-87755766-8235 |
| zhujiay@mail.sysu.edu.cn | |
| Public contact | |
| Name of contact person | Peng Wang |
| Organization | The First Affiliated Hospital of Sun Yat-sen University |
| Division name | Department of Burn Surgery |
| Address | 58 Zhongshan Road II, Guangzhou 510080, China |
| TEL | 86-20-87755766-8235 |
| Homepage URL | |
| wangp46@mail2.sysu.edu.cn | |
| Sponsor | |
| Institute | The First Affiliated Hospital of Sun Yat-sen University
Department of Burn Surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Natural Science Foundation of China (No. 81471875), Sun Yat-sen University Clinical Research 5010 Program (No. 2013001) |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037195 |